Table 1

SBP, DBP and PP during the study period by treatment group, repeated measures and Bonferroni post hoc analysis, using last observation carried forward method for missing data
PJ Placebo P***** for PJ vs. placebo at zero time and at 12 m
Time N Mean ± SE (mm Hg) P for trend N Mean ± SE (mm Hg) P for trend
SBP 0 44 145.6 ± 21.9 0.001 21 129.6 ± 27.2 0.15 0.28
3 M 143.6 ± 23.9 131.2 ± 25.5
6 M 141.7 ± 20.4 138.8 ± 24.8
12 M 135.7 ± 21.3* 135.6 ± 27.7 0.96
SBP ≥ 140 at study initiation 0 26 157.8 ± 12.9 <0.001 5 162.0 ± 10.6 0.42 0.54
3 M 153.2 ± 18.8 157.1 ± 13.9
6 M 149.5 ± 14.8** 156.2 ± 17.6
12 M 144.0 ± 16.9* 157.8 ± 10.3 0.12
DBP†† 0 44 70.9 ± 11.4 0.09 21 62.0 ± 15.7 0.46 0.09
3 M 70.6 ± 12.3 64.5 ± 13.5
6 M 69.6 ± 12.5 61.5 ± 16.5
12 M 67.7 ± 13.8 63.8 ± 20.4 0.38
PP††† 0 44 74.6 ± 19.5 0.04 21 64.3 ± 16.1 0.02 0.24
3 M 72.9 ± 20.0 66.5 ± 19.2
6 M 72.1 ± 17.0 77.3 ± 14.5****
12 M 68.0 ± 16.6*** 68.8 ± 14.2 0.84

*P < 0.05 for 12 m vs. 0 m and 3 m; **P < 0.05 for 6 m vs. zero time; ***P < 0.05 for 12 m vs. zero time; ****P < 0.05 for 6 m vs. zero time; *****T-test or Mann-whitny U test; †Systolic blood pressure; ††Diastolic blood pressure; ††† Pulse pressure.

Shema-Didi et al.

Shema-Didi et al. Nutrition Journal 2014 13:18   doi:10.1186/1475-2891-13-18

Open Data